Charcot Marie Tooth Disease
Conditions
Keywords
CMT
Brief summary
It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are arbitrary. This study is looking to base mild, moderate, and severe on what both people affected with CMT and those who provide for people with CMT consider appropriate.
Interventions
None listed
Sponsors
National Institute of Neurological Disorders and Stroke (NINDS)
Muscular Dystrophy Association
University of Iowa
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* patients with CMT ages 8-100, * health care professionals who take care of patients with CMT. * Eligible patients will be patients that have joined the INC RDCRN Contact Registry. These will be patients or guardians with known or probable inherited neuropathies. * Eligible health care professionals who participate in the care of patients with inherited neuropathies (physicians, genetic counselors, physical and occupational therapists etc.) attending the 4th International CMT Consortium to be held in Potomac Maryland June 29-July 1, 2011.
Exclusion criteria
* Does not read or speak English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare Patient and Healthcare Provider impressions of what constitutes mild, moderate and severe impairment in CMT | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Develop a Disability Severity Index including items with high patient-physician concordance | 1 year |
Countries
United States
Outcome results
None listed